Home › Research › Caregiving
2025 Alzheimer's disease facts and figures
Alzheimer s & Dementia, 2025-04-01
Topic: Amyloid, tau and blood-test diagnosis
However, 2023 data indicate that Alzheimer's will likely resume its place as the sixth‐leading cause of death. These figures reflect a decline in the number of caregivers compared with a decade earlier and an increase in the amount of care provided by each remaining caregiver. Its costs, however, extend to unpaid caregivers’ increased risk for emotional distress and negative mental and physical health outcomes. Based on survey results, most Americans believe early detection of Alzheimer's is important, and nearly all would want a simple diagnostic test if it were available to allow for early diagnosis and treatment.
Key findings
- However, 2023 data indicate that Alzheimer's will likely resume its place as the sixth‐leading cause of death.
- These figures reflect a decline in the number of caregivers compared with a decade earlier and an increase in the amount of care provided by each remaining caregiver.
- Its costs, however, extend to unpaid caregivers’ increased risk for emotional distress and negative mental and physical health outcomes.
- Based on survey results, most Americans believe early detection of Alzheimer's is important, and nearly all would want a simple diagnostic test if it were available to allow for early diagnosis and treatment.
Why it matters
This report presents 2025 Alzheimer's disease facts and figures, noting that 2023 data indicate Alzheimer's will likely resume its place as the sixth-leading cause of death, that the number of caregivers has declined while the amount of care provided by each remaining caregiver has increased, and that unpaid caregivers face increased risk for emotional distress and negative mental and physical health outcomes. It also reports survey results that most Americans believe early detection is important and nearly all would want a simple diagnostic test if available, but it does not report results on treating, curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Evidence strengthLow
How this study scored 56/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 52 of the 93 points we could judge it on, which is 56 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 468 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 156.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 6 / 6 | Cited 290.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 34 other studies in this library |
| Still being cited | 4 / 4 | Cited 462 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 52 / 93 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 52 of the 93 points we could judge it on is 56 out of 100. |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. This record has no authors, so the citation leaves them out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
2025 Alzheimer's disease facts and figures. (2025). Alzheimer s & Dementia. https://doi.org/10.1002/alz.70235
Vancouver
2025 Alzheimer's disease facts and figures. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70235.
BibTeX
@article{study2025-13438b83,
title = {{2025 Alzheimer's disease facts and figures}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.70235},
url = {https://doi.org/10.1002/alz.70235}
}
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 214.
Later studies that cite this one
34 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.